Who
Walter H. Moos
Director
Company insider
Files Form 4 as: Director, Rigel Pharmaceuticals.
In numbers
- Trades disclosed
- 36
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $291K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 May 2006
- Last trade
- 15 May 2026
- Last filed
- 19 May 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 May 2026filed 19 May 2026 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $96K4,000 at $24.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $145K4,000 at $36.36 | filing |
| 20 Feb 2026filed 24 Feb 2026 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $96K4,000 at $24.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $145K4,000 at $36.36 | filing |
| 23 May 2025filed 28 May 2025 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 23 May 2025filed 28 May 2025 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 25 May 2024filed 29 May 2024 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 May 2024filed 29 May 2024 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 26 May 2023filed 12 Jul 2023 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 26 May 2023filed 12 Jul 2023 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 20 May 2022filed 23 May 2022 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 20 May 2022filed 23 May 2022 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 19 May 2021filed 21 May 2021 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 19 May 2021filed 21 May 2021 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 15 May 2020filed 15 May 2020 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 23 May 2019filed 24 May 2019 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.